Recombinant protein therapeutics need a Kühlverpackung plan that protects the molecule and the release record. These products can be sensitive to heat, Einfrieren, Agitation, Licht, and repeated handoff. A good cold-chain package should keep the product inside its qualified range, avoid direct frozen contact, limit vial or syringe movement, and provide temperature evidence for quality review.
Recombinant protein therapeutic planning data
| Typischer Zielbereich | Most refrigerated recombinant protein products are planned around 2-8 C unless the label or stability protocol sets another range. |
|---|---|
| Feuchtigkeitskontrolle | Keep cartons, Etiketten, vial trays, and IFU documents dry; condensation can complicate visual inspection and receiving records. |
| Vorkühlung | Precondition the insulated shipper, Kühlmittel, and buffer materials before loading product from qualified refrigerated storage. |
| Verpackungsdruck | Support vials, Spritzen, or cartridges so secondary packaging is not crushed by coolant mass or transit vibration. |
| Kühlmittelposition | Use conditioned PCM or gel packs with a buffer layer. Avoid frozen-wall contact that can denature or aggregate protein product. |
| Transportdauer | Commonly validated for 24-96 h lanes depending on payload mass, Versendergröße, Kühlmittelaufbereitung, und Umgebungsprofil. |
| Häufige Verluste | Temperaturexkursion, freeze contact, protein aggregation risk, label wetting, carton crush, and missing route records. |
| Tempk packaging fit | Qualified insulated shipper, 2-8 C PCM, buffer insert, vial tray support, absorbierende Schicht, tamper seal, and logger record. |
Why recombinant proteins need product-specific handling
Recombinant protein products are often shipped in vials, prefilled syringes, Patronen, or secondary cartons. The payload can be small, which means it may be more exposed to cold-wall effects if frozen coolant is placed too close. The same product may also be vulnerable to warm route dwell, Feuchtigkeit im Karton, and physical shock that affects presentation or inspection.
Tempk would normally start by confirming the product label, stability range, Streckendauer, und Freigabekriterien. The packout should include conditioned 2-8 C PCM or Gelpackungen, a buffer layer, product support tray, Saugfähige Einlage, and a logger positioned in the payload zone. For higher-value lanes, add an edge logger near the expected coldest or warmest point.
Recommended Tempk approach
Use the actual vial or syringe count, Ausgangsprodukttemperatur, Versendergröße, Kühlmittelaufbereitung, Umgebungsprofil, and courier handoff timing in validation. Receiving checks should include temperature trace, carton dryness, vial or syringe condition, Lesbarkeit des Etiketts, tamper seal, und Streckenzeit. The eCFR requires drug products to be stored under appropriate conditions of temperature, Luftfeuchtigkeit, and light so identity, Stärke, Qualität, and purity are not affected; the packaging should support that expectation in real distribution lanes.
